Der blev udført en samlet evaluering frem til 30. september 2007 af alle hepatiske bivirkninger (alvorlige og ikke- alvorlige) og en samlet vurdering af benefit/ risk- forholdet for moxifloxacin- behandling.
A cumulative review up to 30 September 2007 of all hepatic reactions (serious and non-serious) and an overall assessment of the benefit/ risk ratio of moxifloxacin treatment was performed.